BR0002507A - Derivados da 3- (3-hidróxifenil)-3-amino-propionamida - Google Patents

Derivados da 3- (3-hidróxifenil)-3-amino-propionamida

Info

Publication number
BR0002507A
BR0002507A BR0002507-0A BR0002507A BR0002507A BR 0002507 A BR0002507 A BR 0002507A BR 0002507 A BR0002507 A BR 0002507A BR 0002507 A BR0002507 A BR 0002507A
Authority
BR
Brazil
Prior art keywords
hydroxyphenyl
amino
propionamide derivatives
compounds
propionamide
Prior art date
Application number
BR0002507-0A
Other languages
English (en)
Inventor
Spiros Liras
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0002507A publication Critical patent/BR0002507A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Abstract

"DERIVADOS DA 3-(3-HIDROXIFENIL)-3-AMINO-PROPIONAMIDA". A presente invenção refere-se a compostos da fórmula I, em que X, Y, R^ 1^, R^ 2^ e R^ 3^ são como definidos na especificação, com as formulações farmacêuticas contendo estes compostos e com a utilização destes compostos no tratamento de distúrbios neurológicos e gastrintestinais.
BR0002507-0A 1999-05-28 2000-05-29 Derivados da 3- (3-hidróxifenil)-3-amino-propionamida BR0002507A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13654899P 1999-05-28 1999-05-28

Publications (1)

Publication Number Publication Date
BR0002507A true BR0002507A (pt) 2003-01-28

Family

ID=22473319

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0002507-0A BR0002507A (pt) 1999-05-28 2000-05-29 Derivados da 3- (3-hidróxifenil)-3-amino-propionamida

Country Status (9)

Country Link
EP (1) EP1055665B1 (pt)
JP (1) JP3627975B2 (pt)
AT (1) ATE252546T1 (pt)
BR (1) BR0002507A (pt)
CA (1) CA2309439C (pt)
DE (1) DE60006032T2 (pt)
DK (1) DK1055665T3 (pt)
ES (1) ES2206139T3 (pt)
PT (1) PT1055665E (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838580B2 (en) * 2002-01-29 2005-01-04 Teikoku Seiyaku Co., Ltd. Opioid derivative
ATE516274T1 (de) * 2004-03-15 2011-07-15 Janssen Pharmaceutica Nv Neue verbindungen als modulatoren des opioidrezeptors
AU2013205089B2 (en) * 2004-03-15 2013-12-19 Janssen Pharmaceutica, N.V. Novel compounds as opioid receptor modulators
EP1863764A1 (en) * 2005-03-14 2007-12-12 Janssen Pharmaceutica, N.V. Process for the preparation of opioid modulators
CA3096059A1 (en) * 2018-04-04 2019-10-10 Epiodyne, Inc. Opioid receptor modulators and products and methods related thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272175A (en) * 1992-05-20 1993-12-21 G. D. Searle & Co. Substituted tyrosyl diamide compounds
US5389645A (en) * 1992-08-13 1995-02-14 G. D. Searle & Co. Substituted tyrosyl diamine amide compounds
WO1996022276A1 (fr) * 1995-01-20 1996-07-25 Nippon Shinyaku Co., Ltd. Derives d'ethylamine et medicaments

Also Published As

Publication number Publication date
DE60006032T2 (de) 2004-06-17
ATE252546T1 (de) 2003-11-15
DK1055665T3 (da) 2004-03-01
JP2000351756A (ja) 2000-12-19
DE60006032D1 (de) 2003-11-27
EP1055665A1 (en) 2000-11-29
JP3627975B2 (ja) 2005-03-09
CA2309439A1 (en) 2000-11-28
CA2309439C (en) 2004-10-05
ES2206139T3 (es) 2004-05-16
EP1055665B1 (en) 2003-10-22
PT1055665E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
CA2343236A1 (en) 4,4-biarylpiperidine derivatives
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE60219954D1 (de) Neue Indol-2-on Derivate
PT992509E (pt) Novos derivados macrolidos
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
DE59909607D1 (de) Tan-1057 derivate
BR0002507A (pt) Derivados da 3- (3-hidróxifenil)-3-amino-propionamida
ID25478A (id) Agonis 5-ht1f
CA2299036A1 (en) 4-phenyl-4-heteroarylpiperidine derivatives
EP1057829A4 (en) Condensed pyrimidine derivatives and pharmaceutical compositions containing them
BR0210749A (pt) Composições de fragrância e sabor
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
BR9900024A (pt) Biciclo[3.1.0]hexanos e compostos relacionados.
WO2000078751A3 (en) Compounds for use in treatment of neurological disorders
ECSP993220A (es) Derivados de 3,3- biarilpiperidina y 2,2 - biarilmorfolina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.